“antibodies” Archives

Entry Author Date Location
Alnylam Gets $25M From Medicines Co. for Cholesterol Drug 02/04/13 Boston
Alder Biopharma Looks to Take On Migraines, and the World 01/24/13 Seattle
Sutro Strikes Celgene Deal Worth Up to $500M 12/18/12 San Francisco
Seattle Genetics Gets $25M in Broader Abbott Deal 10/23/12 Seattle
Genentech, ImmunoGen Souped-Up Breast Cancer Drug Extends Lives 10/01/12 San Francisco
Zymeworks Hits Antibody Drug Milestone For Merck, Raises $11M 09/06/12 Seattle
Merck Bets $15M on Ambrx’s “Smart Bomb” Antibodies 06/18/12 San Diego
Theraclone Takes 2nd Antibody into the Clinic Against Common Virus 06/14/12 Seattle
Genentech, ImmunoGen ‘Smart Bomb’ for Breast Cancer Blazes New Trail 06/03/12 San Francisco
SD Biotech Roundup: Elevation Pharmaceuticals, BioSurplus, and More 05/17/12 San Diego
Targeted Cancer Drugs With Punch: The Next Big Class of Antibodies 05/16/12 National
Sutro Biopharma Pulls in $16M for New Antibody Drugs 05/08/12 San Francisco
Theraclone Names Cliff Stocks, Vet of Icos & Calistoga, as New CEO 12/06/11 Seattle
Genentech, ImmunoGen’s Souped-Up Antibody for Breast Cancer Passes Key Test 09/24/11 San Francisco
The Immunex Impact, Calypso Gets Acquired, Women in Bio’s Kickoff, & More in Seattle-Area Life Sciences News 09/22/11 Seattle
Theraclone Enters Clinical World, With Flu Antibody That Might Be Handy in Pandemic 09/21/11 Seattle
Theraclone Snaps Up $10.6M Financing 09/08/11 Seattle
Theraclone Sniffs Around for $10M, Dendreon Gets Third Factory OK, Zymeworks’ Big Merck Deal, & More Seattle-Area Life Sciences News 09/08/11 Seattle
Theraclone Nabs Industry Award, Scopes Out Extra $10M Financing 09/06/11 Seattle
Xoma CEO Resigns After Four-Year Push To Go Commercial 08/31/11 San Francisco
Zymeworks Snags $187M Deal With Merck to Discover Multi-Pronged Antibodies 08/29/11 Seattle
Seattle Genetics, On the Verge of Going Commercial, Seeks to Keep Its Scientific Soul 07/05/11 Seattle
Excelimmune Grabs $10.5M, Aveo Gets $15M In J&J Deal, Myriant Aims for $125M IPO, & More Boston-Area Deals News 06/01/11 Boston
ImmunoGen Grabs $84M 05/20/11 Boston
SeaGen Ends March With $456M Cash 05/05/11 Seattle
Dyax, FivePrime Cut Antibody Deal 04/26/11 Boston
Genmab Expands SeaGen Alliance 04/19/11 Seattle
Alder Steers Next Antibodies To Unusual Places: Treating Migraines and High Cholesterol 03/02/11 Seattle
Amgen Pushes Ahead With ‘Son of Dmab’ For Treating Broken, Frail Bones 02/09/11 National
Secretive Biotech Arsanis Raises $9.6M 02/08/11 Boston
Page 2 of 5 « previous page · next page »